Investor mix
4 investors on record; lead investors include AVANTECA, Zurcher Kantonalbank.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Accelerator & incubator | 2 | 50% |
| Other / undisclosed | 1 | 25% |
Developer of immunotherapies for the treatment of breast cancer
4 investors on record; lead investors include AVANTECA, Zurcher Kantonalbank.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Accelerator & incubator | 2 | 50% |
| Other / undisclosed | 1 | 25% |